{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:47:21Z","timestamp":1792698441272,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Massive intra-articular infiltration of proinflammatory macrophages is a prominent feature of rheumatoid arthritis (RA) lesions, which are thought to underlie articular immune dysfunction, severe synovitis and ultimately joint erosion. Here we report an efferocytosis-informed nanoimitator (EINI) for in situ targeted reprogramming of synovial inflammatory macrophages (SIMs) that thwarts their autoimmune attack and reestablishes articular immune homeostasis, which mitigates RA. The EINI consists of a drug-based core with an oxidative stress-responsive phosphatidylserine (PtdSer) corona and a shell composed of a P-selectin-blocking motif, low molecular weight heparin (LMWH). When systemically administered, the LMWH on the EINI first binds to P-selectin overexpressed on the endothelium in subsynovial capillaries, which functions as an antagonist, disrupting neutrophil synovial trafficking. Due to the strong dysregulation of the synovial microvasculature, the EINI is subsequently enriched in the joint synovium where the shell is disassembled upon the reactive oxygen species stimulation, and PtdSer corona is then exposed. In an efferocytosis-like manner, the PtdSer-coroneted core is in turn phagocytosed by SIMs, which synergistically terminate SIM-initiated pathological cascades and serially reestablish intra-articular immune homeostasis, conferring a chondroprotective effect. These findings demonstrate that SIMs can be precisely remodeled via the efferocytosis-mimetic strategy, which holds potential for RA treatment.<\/jats:p>","DOI":"10.1038\/s41467-023-36468-2","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T15:05:25Z","timestamp":1676300725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Remodeling articular immune homeostasis with an efferocytosis-informed nanoimitator mitigates rheumatoid arthritis in mice"],"prefix":"10.1038","volume":"14","author":[{"given":"Shengchang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihao","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhentao","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohnad","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongchang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7795-8933","authenticated-orcid":false,"given":"Yuankai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0074-6876","authenticated-orcid":false,"given":"Xinyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"36468_CR1","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC201901010","volume":"170","author":"JA Sparks","year":"2019","unstructured":"Sparks, J. A. Rheumatoid arthritis. Ann. Intern. Med. 170, ITC1\u2013ITC16 (2019).","journal-title":"Ann. Intern. Med."},{"key":"36468_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein, G. S. & McInnes, I. B. Immunopathogenesis of rheumatoid arthritis. Immunity 46, 183\u2013196 (2017).","journal-title":"Immunity"},{"key":"36468_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo, Q. et al. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 6, 15 (2018).","journal-title":"Bone Res."},{"key":"36468_CR4","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/art.39269","volume":"67","author":"M Feldmann","year":"2015","unstructured":"Feldmann, M. & Maini, R. N. Perspectives from masters in rheumatology and autoimmunity: can we get closer to a cure for rheumatoid arthritis? Arthritis Rheumatol. 67, 2283\u20132291 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"36468_CR5","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1136\/annrheumdis-2015-207838","volume":"75","author":"A Richter","year":"2016","unstructured":"Richter, A. et al. Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis. Ann. Rheum. Dis. 75, 1667 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"36468_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes, I. B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429\u2013442 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"36468_CR7","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen, J. S. et al. Rheumatoid arthritis. Nat. Rev. Dis. Prim. 4, 18001 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"36468_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrrheum.2016.91","volume":"12","author":"IA Udalova","year":"2016","unstructured":"Udalova, I. A., Mantovani, A. & Feldmann, M. Macrophage heterogeneity in the context of rheumatoid arthritis. Nat. Rev. Rheumatol. 12, 472\u2013485 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"36468_CR9","doi-asserted-by":"publisher","first-page":"102369","DOI":"10.1016\/j.autrev.2019.102369","volume":"18","author":"P Di Benedetto","year":"2019","unstructured":"Di Benedetto, P., Ruscitti, P., Vadasz, Z., Toubi, E. & Giacomelli, R. Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases. Autoimmun. Rev. 18, 102369 (2019).","journal-title":"Autoimmun. Rev."},{"key":"36468_CR10","doi-asserted-by":"publisher","first-page":"e1003296","DOI":"10.1371\/journal.pmed.1003296","volume":"17","author":"XME Matthijssen","year":"2020","unstructured":"Matthijssen, X. M. E., Niemantsverdriet, E., Huizinga, T. W. J. & van der Helm\u2013van Mil, A. H. M. Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: a longitudinal cohort study in the Netherlands. PLOS Med. 17, e1003296 (2020).","journal-title":"PLOS Med."},{"key":"36468_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nri.2016.124","volume":"17","author":"V Malmstr\u00f6m","year":"2017","unstructured":"Malmstr\u00f6m, V., Catrina, A. I. & Klareskog, L. The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat. Rev. Immunol. 17, 60\u201375 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"36468_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ni.1990","volume":"12","author":"T Krausgruber","year":"2011","unstructured":"Krausgruber, T. et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12, 231\u2013238 (2011).","journal-title":"Nat. Immunol."},{"key":"36468_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature03308","volume":"434","author":"A Takaoka","year":"2005","unstructured":"Takaoka, A. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243\u2013249 (2005).","journal-title":"Nature"},{"key":"36468_CR14","doi-asserted-by":"publisher","first-page":"11001","DOI":"10.1073\/pnas.1506254112","volume":"112","author":"M Weiss","year":"2015","unstructured":"Weiss, M. et al. IRF5 controls both acute and chronic inflammation. Proc. Natl Acad. Sci. 112, 11001 (2015).","journal-title":"Proc. Natl Acad. Sci."},{"key":"36468_CR15","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/art.23426","volume":"58","author":"R Dieguez-Gonzalez","year":"2008","unstructured":"Dieguez-Gonzalez, R. et al. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis. Arthritis Rheum. 58, 1264\u20131274 (2008).","journal-title":"Arthritis Rheum."},{"key":"36468_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/ng1782","volume":"38","author":"RR Graham","year":"2006","unstructured":"Graham, R. R. et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 38, 550\u2013555 (2006).","journal-title":"Nat. Genet."},{"key":"36468_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-cellbio-111315-125315","volume":"33","author":"PM Henson","year":"2017","unstructured":"Henson, P. M. Cell removal: efferocytosis. Annu. Rev. Cell Dev. Biol. 33, 127\u2013144 (2017).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"36468_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nri3607","volume":"14","author":"IKH Poon","year":"2014","unstructured":"Poon, I. K. H., Lucas, C. D., Rossi, A. G. & Ravichandran, K. S. Apoptotic cell clearance: basic biology and therapeutic potential. Nat. Rev. Immunol. 14, 166\u2013180 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"36468_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tcb.2015.08.003","volume":"25","author":"K Segawa","year":"2015","unstructured":"Segawa, K. & Nagata, S. An apoptotic \u2018Eat Me\u2019 signal: phosphatidylserine exposure. Trends Cell Biol. 25, 639\u2013650 (2015).","journal-title":"Trends Cell Biol."},{"key":"36468_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrrheum.2016.69","volume":"12","author":"U Fearon","year":"2016","unstructured":"Fearon, U., Canavan, M., Biniecka, M. & Veale, D. J. Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis. Nat. Rev. Rheumatol. 12, 385\u2013397 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"36468_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cbi.2017.12.024","volume":"281","author":"A-R Phull","year":"2018","unstructured":"Phull, A.-R., Nasir, B., Haq, I. U. & Kim, S. J. Oxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritis. Chem.-Biol. Interact. 281, 121\u2013136 (2018).","journal-title":"Chem.-Biol. Interact."},{"key":"36468_CR22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1365-2818.1993.tb03313.x","volume":"169","author":"EMM Manders","year":"1993","unstructured":"Manders, E. M. M., Verbeek, F. J. & Aten, J. A. Measurement of co-localization of objects in dual-colour confocal images. J. Microsc. 169, 375\u2013382 (1993).","journal-title":"J. Microsc."},{"key":"36468_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1172\/JCI0214996","volume":"110","author":"L Wang","year":"2002","unstructured":"Wang, L., Brown, J. R., Varki, A. & Esko, J. D. Heparin\u2019s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J. Clin. Investig. 110, 127\u2013136 (2002).","journal-title":"J. Clin. Investig."},{"key":"36468_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nm.3798","volume":"21","author":"K Liddiard","year":"2015","unstructured":"Liddiard, K. & Taylor, P. R. Understanding local macrophage phenotypes in disease: shape-shifting macrophages. Nat. Med. 21, 119\u2013120 (2015).","journal-title":"Nat. Med."},{"key":"36468_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/eji.201445427","volume":"46","author":"EL Mills","year":"2016","unstructured":"Mills, E. L. & O\u2019Neill, L. A. Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal. Eur. J. Immunol. 46, 13\u201321 (2016).","journal-title":"Eur. J. Immunol."},{"key":"36468_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cmet.2018.09.019","volume":"29","author":"S Soberanes","year":"2019","unstructured":"Soberanes, S. et al. Metformin targets mitochondrial electron transport to reduce air-pollution-induced thrombosis. Cell Metab. 29, 335\u2013347 (2019).","journal-title":"Cell Metab."},{"key":"36468_CR27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand, D. D., Latham, K. A. & Rosloniec, E. F. Collagen-induced arthritis. Nat. Protoc. 2, 1269\u20131275 (2007).","journal-title":"Nat. Protoc."},{"key":"36468_CR28","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1136\/annrheumdis-2021-220043","volume":"80","author":"GR Meehan","year":"2021","unstructured":"Meehan, G. R. et al. Preclinical models of arthritis for studying immunotherapy and immune tolerance. Ann. Rheum. Dis. 80, 1268\u20131277 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"36468_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41563-019-0462-9","volume":"19","author":"Y Lee","year":"2020","unstructured":"Lee, Y. et al. Hyaluronic acid\u2013bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis. Nat. Mater. 19, 118\u2013126 (2020).","journal-title":"Nat. Mater."},{"key":"36468_CR30","doi-asserted-by":"publisher","first-page":"ii13","DOI":"10.1093\/jac\/dkw392","volume":"71","author":"M Bassetti","year":"2016","unstructured":"Bassetti, M., Peghin, M. & Timsit, J.-F. The current treatment landscape: candidiasis. J. Antimicrob. Chemother. 71, ii13\u2013ii22 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"36468_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12275-011-1064-7","volume":"49","author":"J Kim","year":"2011","unstructured":"Kim, J. & Sudbery, P. Candida albicans, a major human fungal pathogen. J. Microbiol. 49, 171\u2013177 (2011).","journal-title":"J. Microbiol."},{"key":"36468_CR32","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester, G. R. & Pope, J. E. Novel treatment strategies in rheumatoid arthritis. Lancet 389, 2338\u20132348 (2017).","journal-title":"Lancet"},{"key":"36468_CR33","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann. Rheum. Dis. 76, 960 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"36468_CR34","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41551-019-0360-0","volume":"3","author":"P Zhao","year":"2019","unstructured":"Zhao, P. et al. Depletion of PD-1-positive cells ameliorates autoimmune disease. Nat. Biomed. Eng. 3, 292\u2013305 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"36468_CR35","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.autrev.2018.06.006","volume":"17","author":"I Cecchi","year":"2018","unstructured":"Cecchi, I. et al. Neutrophils: novel key players in rheumatoid arthritis. Current and future therapeutic targets. Autoimmun. Rev. 17, 1138\u20131149 (2018).","journal-title":"Autoimmun. Rev."},{"key":"36468_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/ncprheum0559","volume":"3","author":"D Lainer-Carr","year":"2007","unstructured":"Lainer-Carr, D. & Brahn, E. Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat. Clin. Pract. Rheumatol. 3, 434\u2013442 (2007).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"36468_CR37","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","volume":"20","author":"F Zhang","year":"2019","unstructured":"Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 20, 928\u2013942 (2019).","journal-title":"Nat. Immunol."},{"key":"36468_CR38","doi-asserted-by":"publisher","first-page":"102758","DOI":"10.1016\/j.autrev.2021.102758","volume":"20","author":"M-A Boutet","year":"2021","unstructured":"Boutet, M.-A. et al. Novel insights into macrophage diversity in rheumatoid arthritis synovium. Autoimmun. Rev. 20, 102758 (2021).","journal-title":"Autoimmun. Rev."},{"key":"36468_CR39","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/annrheumdis-2019-215920","volume":"78","author":"S Safiri","year":"2019","unstructured":"Safiri, S. et al. Global, regional and national burden of rheumatoid arthritis 1990\u20132017: a systematic analysis of the global burden of disease study 2017. Ann. Rheum. Dis. 78, 1463 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"36468_CR40","doi-asserted-by":"publisher","first-page":"E1463","DOI":"10.1073\/pnas.1320174111","volume":"111","author":"GT Tietjen","year":"2014","unstructured":"Tietjen, G. T. et al. Molecular mechanism for differential recognition of membrane phosphatidylserine by the immune regulatory receptor Tim4. Proc. Natl Acad. Sci. 111, E1463 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"36468_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-immunol-081619-104850","volume":"38","author":"DG Ryan","year":"2020","unstructured":"Ryan, D. G. & O\u2019Neill, L. A. J. Krebs cycle reborn in macrophage immunometabolism. Annu. Rev. Immunol. 38, 289\u2013313 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"36468_CR42","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/ard.2010.142091","volume":"70","author":"L Laurent","year":"2011","unstructured":"Laurent, L. et al. Fc\u03b3 receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins. Ann. Rheum. Dis. 70, 1052 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"36468_CR43","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1136\/annrheumdis-2015-208887","volume":"75","author":"C Clavel","year":"2016","unstructured":"Clavel, C., Ceccato, L., Anquetil, F., Serre, G. & Sebbag, M. Among human macrophages polarised to different phenotypes, the M-CSF-oriented cells present the highest pro-inflammatory response to the rheumatoid arthritis-specific immune complexes containing ACPA. Ann. Rheum. Dis. 75, 2184 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"36468_CR44","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3389\/fimmu.2017.01958","volume":"8","author":"S Fukui","year":"2017","unstructured":"Fukui, S., Iwamoto, N., Takatani, A., Igawa, T. & Kawakami, A. M1 and M2 monocytes in rheumatoid arthritis: a contribution of imbalance of M1\/M2 monocytes to osteoclastogenesis. Front Immunol. 8, 1958 (2017).","journal-title":"Front Immunol."},{"key":"36468_CR45","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s10753-015-0188-z","volume":"38","author":"W Zhu","year":"2015","unstructured":"Zhu, W. et al. Anti-citrullinated protein antibodies induce macrophage subset disequilibrium in RA patients. Inflammation 38, 2067\u20132075 (2015).","journal-title":"Inflammation"},{"key":"36468_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25246-7","volume":"12","author":"X Wu","year":"2021","unstructured":"Wu, X. et al. Single-cell sequencing of immune cells from anticitrullinated peptide antibody positive and negative rheumatoid arthritis. Nat. Commun. 12, 4977 (2021).","journal-title":"Nat. Commun."},{"key":"36468_CR47","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/s41565-018-0254-4","volume":"13","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat. Nanotechnol. 13, 1182\u20131190 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"36468_CR48","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1084\/jem.20051310","volume":"203","author":"T Honda","year":"2006","unstructured":"Honda, T., Segi-Nishida, E., Miyachi, Y. & Narumiya, S. Prostacyclin-IP signaling and prostaglandin E2-EP2\/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J. Exp. Med. 203, 325\u2013335 (2006).","journal-title":"J. Exp. Med."},{"key":"36468_CR49","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41551-021-00797-8","volume":"5","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells. Nat. Biomed. Eng. 5, 1288\u20131305 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"36468_CR50","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.7150\/thno.29313","volume":"8","author":"M Ammari","year":"2018","unstructured":"Ammari, M. et al. Delivery of miR-146a to Ly6Chigh monocytes inhibits pathogenic bone erosion in inflammatory arthritis. Theranostics 8, 5972\u20135985 (2018).","journal-title":"Theranostics"},{"key":"36468_CR51","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/scitranslmed.aaa4616","volume":"7","author":"KM Doody","year":"2015","unstructured":"Doody, K. M. et al. Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy. Sci. Transl. Med. 7, 276\u2013288 (2015).","journal-title":"Sci. Transl. Med."},{"key":"36468_CR52","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","volume":"28","author":"MJ Lewis","year":"2019","unstructured":"Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep. 28, 2455\u20132470 (2019).","journal-title":"Cell Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36468-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T06:13:58Z","timestamp":1676355238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36468-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36468"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-36468-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1159315\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"817"}}